共 6 条
[1]
NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model[J] . Norihisa Ishiwata,Kazuo Noguchi,Masafumi Kawanishi,Yumiko Asakura,Miyuki Hori,Akiko Mitani,Yusuke Ito,Kanako Takahashi,Hiroshi Nishiyama,Norimasa Shudo,Shuya Takahashi,Kenzo Takahashi,Nobutomo Tsuruzoe,Shiro Nakaike.Life Sciences . 2007 (12)
[2]
Current developments in anti-platelet therapy[J] . Florian B. Mayr,Bernd Jilma.Wiener Medizinische Wochenschrift . 2006 (17)
[3]
Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development[J] . Y. H. Jeon,Y. -S. Heo,C. M. Kim,Y. -L. Hyun,T. G. Lee,S. Ro,J. M. Cho.Cellular and Molecular Life Sciences . 2005 (11)
[4]
Toborinone and olprinone, phosphodiesterase III inhibitors, inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry[J] . Kyoko Kageyama,Toshiki Mizobe,Shinji Nozuchi,Noriko Hiramatsu,Yasufumi Nakajima,Hiroshi Aoki.Journal of Anesthesia . 2004 (2)
[5]
Comparison of the Effects of Cilostazol and Milrinone on cAMP-PDE Activity, Intracellular cAMP and Calcium in the Heart[J] . Yasmin Shakur,Miranda Fong,James Hensley,James Cone,Matthew A. Movsesian,Jun-ichi Kambayashi,Masuhiro Yoshitake,Yongge Liu.Cardiovascular Drugs and Therapy . 2002 (5)
[6]
Ginkgo biloba extract (EGb761): pharmacological activities and clinical applications. DeFeudis FV. Elsevir . 1991